Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950123-09-061517
Filing Date
2009-11-12
Accepted
2009-11-12 10:36:25
Documents
5
Period of Report
2009-09-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q c92008e10vq.htm 10-Q 505432
2 EXHIBIT 31.1 c92008exv31w1.htm EX-31.1 6555
3 EXHIBIT 31.2 c92008exv31w2.htm EX-31.2 6586
4 EXHIBIT 32.1 c92008exv32w1.htm EX-32.1 4029
5 EXHIBIT 32.2 c92008exv32w2.htm EX-32.2 4026
  Complete submission text file 0000950123-09-061517.txt   528376
Mailing Address 750 BATTERY STREET SUITE 330 SAN FRANCISCO CA 94111
Business Address 750 BATTERY STREET SUITE 330 SAN FRANCISCO CA 94111 415-283-2200
VIA Pharmaceuticals, Inc. (Filer) CIK: 0001003929 (see all company filings)

EIN.: 330687976 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-27264 | Film No.: 091175021
SIC: 2836 Biological Products, (No Diagnostic Substances)